Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medicare

Medicare Advantage plans send pals to seniors’ homes for companionship — and profits

Widowed and usually living alone, Gloria Bailey walks with a cane after two knee replacement surgeries and needs help with housekeeping.

Tribune News Service

Critics say Australia's private health insurance system is broken. Here's what they say we can do to fix it

It's a question many Australians are asking when confronted with their private health insurance payments these days: Why are the premiums so high? The answer is complex.

ABC News

GOP's new plan: Tax the poor even more

Rick Scott believes he can get elected president on a program of making inequality great again. He may be right

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Alzheimer’s patients divided on costly new drug: a ‘magic pill’ or ‘risk I’m willing to take’

Medicare has proposed limiting coverage of Aduhelm. Key groups representing patients and families are pressing to make it more widely available. Among people facing the disease, the outlook is more nuanced.

Chicago Sun-Times

Limits on insulin costs revived in push for Senate action

Legislation to limit insulin costs for people with diabetes is getting a new push in the Senate

The Independent UK

This Microcap Pharma Stock Almost Doubled Today - Read Why

UnitedHealthcare has added Kala Pharmaceuticals Inc's (NASDAQ:KALA) Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies effective March 2022. Eysuvis now has coverage for approximately 118 million lives or 70% of all commercial lives. Kala also announced that Cigna Medicare had added Eysuvis as a preferred brand effective…

Benzinga

Most GP visits now bulk-billed: Hunt

Health Minister Greg Hunt says the government remains committed to Medicare with almost nine out 10 GP visits provided with no out-of-pocket cost.

AAP

Read news from The Economist, FT, and more,
with one subscription

Medicare fraud by providers is rampant and government bulk-billing figures are a ‘lie’, review finds

As few as 30% of patients being properly bulk-billed despite health minister claiming it is nearly 90%, report says

The Guardian - AU

Seeking to shift costs to Medicare, more employers move retirees to advantage plans

As a parting gesture to a pandemic-ravaged city, former New York Mayor Bill de Blasio hoped to provide the city with a gift that would keep on giving: new health insurance for 250,000 city retirees partly funded by the federal government. Although he promised better benefits and no change in…

Tribune News Service

IUD insertion Medicare rebate increased but doctors argue it needs to be higher to be affordable

The Medicare rebate for getting an intra-uterine device (IUD) inserted has been raised but doctors say it still does not come close to covering the cost of the procedure.

ABC News

CBT is wrong in how it understands mental illness

Cognitive behavioural therapy (CBT) is one of the most popular forms of talking therapy. It is the treatment of choice for depression and anxiety and is a staple of public healthcare systems, such as the NHS and the Australian Medicare system. CBT’s understanding of mental illness and therapeutic techniques is…

The Conversation

Plan to fix Postal Service shifts new retirees to Medicare — along with billions in costs

A congressional effort to fix the nation’s deteriorating mail service may come at the expense of an even bigger and more complicated problem: Medicare solvency.

Tribune News Service

GPs should be trained to treat more mental health patients to ease ‘national emergency’, peak body says

Royal Australian College of General Practitioners calls for Medicare restructure amid psychiatrist shortage and gaps in regional coverage

The Guardian - AU

The relentless high prices of private health care

The prices are still relentlessly high.

Axios

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Arreglar el Seguro Social animaría la agenda después de las elecciones de mitad de periodo

WASHINGTON— Si los republicanos toman una o ambas cámaras del Congreso en noviembre, no te sorprendas si el fortalecimiento de las finanzas de la Seguro Social se convierte en un área de enfoque bipartidista.

Tribune News Service

Other states keep watchful eye on snags in Washington’s pioneering public-option plan

With prospects dim for the U.S. to adopt a single-payer “Medicare for All” program, health care reform advocates turned instead to an insurance plan designed by the government that could compete with private insurance plans sold on the health care exchanges. The idea behind this “public option” is that it…

Tribune News Service

Social Security fixes could animate post-midterms agenda

WASHINGTON — If Republicans take one or both chambers of Congress in November, don’t be surprised if shoring up Social Security’s finances becomes an area of bipartisan focus.

Roll Call

Social Security fixes could animate post-midterms agenda - Roll Call

Veterans of previous bipartisan working groups in the Senate have begun talking about the need for fixes to counter future shortfalls.

Get all your
news in one place.

100’s of premium titles.
One news app.

Miami Herald

‘Healthiest people got monoclonal antibodies.’ COVID therapy goes to those who need it less

Monoclonal antibodies have emerged as a powerful tool for reducing hospitalization and death from COVID-19, but recently published studies suggests that the lab-created proteins are going to those who need them less — patients with the fewest chronic conditions — while usage in hospital outpatient clinics has followed a persistent…

Tribune News Service

Inside the tactical tug of war over the controversial Alzheimer’s drug

The drug industry, patient advocates and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug. They’ve gone as far as to accuse them of tacit racism, ageism and discrimination against the disabled — and hinted at a lawsuit — over the…

Tribune News Service

Patients’ groups, progressives square off over Medicare Alzheimer’s decision

WASHINGTON — Advocates on both sides of a debate over dramatically restricting Medicare’s coverage of an expensive and controversial Alzheimer’s treatment are waging competing campaigns to influence a final decision in April.

Roll Call

Patients' groups, progressives square off over Medicare Alzheimer's decision - Roll Call

Competing campaigns look to influence the debate over dramatically restricting coverage of a controversial treatment drug Aduhelm.

Tribune News Service

Mayo stops scheduling out-of-network Medicare Advantage patients in Minnesota

Mayo Clinic is not scheduling appointments for seniors in certain Medicare Advantage health plans because their insurers haven't negotiated contracts for in-network access to the world-renowned medical center.

Los Angeles Times

Michael Hiltzik: The government could force a price cut for this prostate cancer drug by as much as 80%. Why hasn't it acted?

Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the taxpayers through the Pentagon and the National Institutes of Health.

The Independent UK

House bill would ease budget strains on Postal Service

The House is close to approving a bipartisan bill that would lift onerous budget requirements that have helped push the Postal Service deeply into debt

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.